Tumor cells co-opt the PD-1/PD-L1 mechanism of immune regulation such that activation of this axis results in suppression of anti-tumor adaptive responses through mechanisms involving induction of CTL anergy, exhaustion, apoptosis and decreased cytokine production [1, 3]. The gene discussed is CD274; the disease is neoplasm.